Garima Sharma, MD, outlines validated cardiac risk scores for antenatal screening and the postpartum transitions needed to keep high-risk patients from being lost to follow-up.
|Articles|August 24, 2020
Gender bias in drug dosage trials and overmedicated women
Author(s)Lindsey Carr, Editor
A new study from the journal Biology of Sex Differences found an association between sex biases in drug dosage trials and the overmedication of women.
Advertisement
According to investigators, women are more likely than men to experience adverse drug reactions from medications, as clinical trials have historically focused on men.
In the August issue of Contemporary OB/GYN, Editor-in-Chief Dr. Catherine Y. Spong discussed the ways in which women’s health research has and continues to be marginalized.
“Only in 1993, with the passage of the National Institutes of Health Revitalization Act, were women mandated to be included in NIH-funded research,” wrote Dr. Spong.
For additional details on the study’s findings, visit our sister publication,
Advertisement
Related to this article
Anti-CGRP antibody exposure in early pregnancy was linked to higher spontaneous abortion risk; propranolol was not.
In the debut episode of Missed & Dismissed, Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, talks with Charis Chambers, MD, about PCOS, the push to rename it PMOS, and why diagnostic delays so often begin in adolescence.
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
Pritelivir healed all HSV lesions by day 28 in 63% of immunocompromised adults vs 34% with comparators.
Fezolinetant (Veozah) was linked to objective and patient-reported sleep gains in OPTION-VMS, with no new safety signals observed.
HPV vaccination before pregnancy was linked to lower odds of preterm birth in a Swedish study of 624,713 births.
The prospective SOARA study will measure how often a 98%-specific ovarian cancer screening blood test leads to invasive procedures.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Evident ovarian cancer screening test: What SOARA will measure
2
FDA approves pritelivir tablets to treat lesions from HSV
3
Anti-CGRP antibodies associated with higher spontaneous abortion risk
4
Wen Shen, MD, on steering patients to evidence-based menopause care
5